Company Encyclopedia
View More
name
PA GOODDOCTOR
01833.HK
Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in China. It offers online medical services, such as online consultation, hospital referral and appointment, inpatient arrangement, and second opinion services; prepaid cards and health check-up services; and beauty care. The company provides advertising and health management services. In addition, it provides medicine marketing services; software and information technology services; application development and operation apps services; and internet hospital and medical services, as well as operates an insurance agency.
318.71 B
01833.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Drug RetailIndustry
Industry Ranking4/7
Industry medianB
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.38%C
    • Profit Margin3.05%C
    • Gross Margin33.56%C
  • Growth ScoreB
    • Revenue YoY14.96%B
    • Net Profit YoY846.36%A
    • Total Assets YoY-18.53%E
    • Net Assets YoY-26.11%E
  • Cash ScoreA
    • Cash Flow Margin3282.18%A
    • OCF YoY14.96%B
  • Operating ScoreD
    • Turnover0.36D
  • Debt ScoreB
    • Gearing Ratio25.15%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    UBS lowers PA GOODDOCTOR's target price to 16.5 yuan with a "Neutral" rating

    UBS has lowered the target price for PA GOODDOCTOR from 20 yuan to 16.5 yuan, with a rating of "Neutral." The bank predicts that PA GOODDOCTOR's revenue compound annual growth rate will reach 12.7% from 2024 to 2027, and expects profit margins to improve. The adjusted net profit margin is expected to rise from 3.3% in 2024 to 9.5% in 2027, and it has raised the earnings per share forecasts for 2025 to 2027 by 216%, 55%, and 32%, respectively

    AASTOCKS·
    HK
    01833
    +2.84%
    AASTOCKS·
    HK
    01833
    +2.84%

    Morgan Stanley: Expects PA GOODDOCTOR to achieve a full-year growth target of 10%, target price HKD 16.3

    Morgan Stanley released a research report stating that PA GOODDOCTOR's revenue in the first three quarters of this year increased by 13.6% year-on-year to 3.72 billion yuan (RMB), net profit increased by 72.6% year-on-year to 184 million yuan, and adjusted net profit increased by 45.7% year-on-year to 216 million yuan. Among them, revenue in the third quarter increased by 3% year-on-year, net profit in the third quarter remained roughly flat, with a net profit margin of 4.1% and an adjusted net profit margin of 4.3%. The bank currently sets a target price of HKD 16.3 and a "market perform" rating. Morgan Stanley believes the company can achieve a full-year revenue growth of over 10% and an adjusted net profit margin of 5% to 6%, which will ultimately depend on the pace of AI investment. On a positive note, the AI technology adopted by the company has improved the treatment accuracy of complex diseases to about 90%, compared to about 80% in the first half of the year, and has reduced the cost of family doctor services by approximately 52% year-on-year

    Zhitong·
    HK
    01833
    +2.84%
    Zhitong·
    HK
    01833
    +2.84%

    After the earnings report, PA GOODDOCTOR faced pressure, dropping over 9% at one point

    After announcing its performance for the first nine months, PA GOODDOCTOR's stock price once fell by more than 9%, currently reported at 14.47 yuan, down 6.52%. The company's revenue for the first three quarters increased by 13.6% year-on-year to 3.725 billion yuan, with a net profit of 184 million yuan, an increase of 72.6%. Morgan Stanley pointed out that the slowdown in growth in the third quarter was affected by deteriorating fundamentals and seasonal factors

    AASTOCKS·
    HK
    01833
    +2.84%
    AASTOCKS·
    HK
    01833
    +2.84%

    Brief: PA GOODDOCTOR's profit surged 72% in the first nine months

    Ping An Health Medical Technology Co., Ltd. announced a 72% increase in profit for the first nine months, reaching 184 million yuan, with revenue rising 13.6% to 3.72 billion yuan. The adjusted net profit was 216 million yuan, an increase of 45.7%. The company benefited from the synergy of medical insurance models, the insurance + medical care membership model, and the advancement of corporate health management services. In the future, it will strengthen collaboration with Ping An Group to promote the digitalization and AI integration of core services. On Friday, the stock price rose by 1.7%, with a year-to-date increase of over 150%

    BambooWorks·
    HK
    01833
    +2.84%
    BambooWorks·
    HK
    01833
    +2.84%

    PA GOODDOCTOR's total revenue for the first three quarters is approximately 3.725 billion yuan, a year-on-year increase of 13.6%. It will continue to expand AI technology to enhance the efficiency and quality of medical services

    PA GOODDOCTOR announced its performance for the first three quarters, with total revenue of approximately 3.725 billion yuan, a year-on-year increase of 13.6%; net profit of 184 million yuan, a year-on-year increase of 72.6%. The company continues to expand its AI technology to improve the efficiency and quality of medical services, with revenue from both F-end and B-end corporate health businesses increasing by 21.5% year-on-year. As of the end of the reporting period, the number of users covered by family doctor membership rights exceeded 40 million, and the number of users benefiting from home elderly care services increased by 41% compared to last year

    Zhitong·
    HK
    01833
    +2.84%
    Zhitong·
    HK
    01833
    +2.84%
    Posts
    View More

    $XTALPI(02228.HK) Goldman Sachs launched the "China AI Healthcare Index" today, with Pharmaron as the top-weighted stock $ALI HEALTH(00241.HK)$JD HEALTH(06618.HK)$PA GOODDOCTOR(01833.HK)$YIDU TECH(021...

    • 0
    © 2025 Longbridge｜Disclaimer